Sale!
,

Peptide Pen Nerve Repair

Original price was: R1375,00.Current price is: R1250,00.

Nerve Repair Pen 50mg ARA-290 (Cibinetide) Peptide Pen delivers targeted nerve regeneration, remyelination & neuropathic pain relief with flexible 10–19 click daily doses.

Heal stronger from within – Order Now!

  • Subcutaneous injection only.
  • Standard Dose: 2–4 mg (10–19 clicks) per injection (common research range scaled for 50 mg pen)
  • Frequency: Once daily or every other day
  • Timing: Consistent daily timing (evening preferred for nerve recovery)
  • Cycle: Typically 4–8 weeks on, followed by 2–4 weeks off

Administration Instructions:

No Content

All Peptide Pen products are intended for laboratory and research purposes only. They are not approved for human consumption, medical use, or therapeutic application. These products are not intended to diagnose, treat, cure, or prevent any disease. Always handle peptides in accordance with proper laboratory safety and research protocols.

Availability: 1 in stock

Product Name: Nerve Repair Pen

Formulation: Prefilled, ready-to-administer Peptide Pen (no reconstitution required)

Active Ingredient: ARA-290 (Cibinetide) – 50 mg per pen

Volume: 2.6 mL

Clicks per Pen: 240

Dosing Mechanism: Precision dial

MG per click: ≈0.208 mg (208 mcg) ARA-290

Supplied with: 6 sterile needles (extras available)

 

Description
ARA-290 (Cibinetide) is a synthetic 11-amino-acid peptide derived from erythropoietin (EPO). It selectively activates the innate repair receptor (IRR) without stimulating red blood cell production. Chemical Structure
Sequence: Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser (pyroglutamate at N-terminus).Mechanism of Action
ARA-290 binds to the tissue-protective IRR complex (EPOR + βcR), triggering potent anti-inflammatory, anti-apoptotic, and regenerative signalling in nerves and other tissues. It promotes:

  • Axonal repair, remyelination, and nerve regeneration
  • Reduction of neuropathic pain and neuroinflammation
  • Improvement of microvascular function and tissue oxygenation
  • Activation of protective pathways (JAK2/STAT3, PI3K/Akt) while avoiding hematopoietic effects

 

Indications & Usage
Nerve Repair (ARA-290 / Cibinetide) is used to support nerve regeneration and neuropathic recovery. It is indicated for:

  • Promotion of peripheral nerve repair and regeneration
  • Reduction of neuropathic pain and neuroinflammation
  • Support for recovery from nerve injury, compression, diabetic neuropathy, or post-surgical nerve damage
  • Assistance in tissue protection and functional recovery

 

Contraindications & Warnings
Do not use if you have:

  • Known hypersensitivity to ARA-290 or any excipient
  • Active malignancy or history of cancer
  • Severe uncontrolled cardiovascular disease
  • Pregnancy or breastfeeding
  • Age under 18 years

 

Warnings

  • Use only under medical supervision with appropriate monitoring.
  • Not a substitute for standard medical or surgical treatment of neuropathy or nerve injury.
  • Monitor for changes in pain levels or neurological function.
  • Discontinue immediately and seek medical attention if severe symptoms occur (e.g., worsening neurological deficits or allergic reaction).

 

Dosage & Administration

  • Subcutaneous injection only.
  • Standard Dose: 2–4 mg (10–19 clicks) per injection (common research range scaled for 50 mg pen)
  • Frequency: Once daily or every other day
  • Timing: Consistent daily timing (evening preferred for nerve recovery)
  • Cycle: Typically 4–8 weeks on, followed by 2–4 weeks off

Administration Instructions:

  1. Wash hands and prepare a clean surface
  2. Attach a sterile needle.
  3. Dial your dose (e.g., 12 clicks ≈ 2.5 mg).
  4. Clean injection site (abdomen or thigh) with alcohol swab.
  5. Insert needle at 45–90° angle and inject slowly.
  6. Withdraw needle, dispose safely, and cap the pen.
  7. Rotate injection sites to minimize irritation.
  8. Always inspect solution: Do not inject if cloudy, discoloured, or containing particles.

 

Side Effects
ARA-290 is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including:

  • Mild injection-site irritation, redness, or itching
  • Transient headache or light-headedness
  • Temporary changes in energy levels or mild fatigue
  • Rare mild gastrointestinal discomfort

If any severe or persistent symptoms occur (e.g., worsening pain, neurological changes, or allergic signs), discontinue use and contact your healthcare provider immediately.

 

Storage & Handling

  • Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25–30°C / 77–86°F).
  • Keep pen capped and protected from light and heat.
  • After first use: Same storage conditions.
  • Keep out of reach of children.
  • Discard if expired or solution appears abnormal.

 

Powered by Precision MSSPT

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector—delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance—providing precision molecular stabilization in every dose, wherever your research takes you.

 

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Shopping Cart
Scroll to Top